Kelly Clive A, et al. |
2014 |
Rheumatoid arthritis‐related interstitial lung disease: associations, prognostic factors and physiological and radiological characteristics‐‐a large multicentre UK study. |
Rheumatology
|
103 |
Joshua J. Solomon, et al. |
2016 |
Predictors of mortality in rheumatoid arthritis‐associated interstitial lung disease. |
Eur Respir J
|
103 |
Charlotte Hyldgaard, et al. |
2017 |
A population‐based cohort study of rheumatoid arthritis‐associated interstitial lung disease: comorbidity and mortality. |
Ann Rheum Dis
|
92 |
P.‐A. Juge, et al. |
2018 |
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease. |
New Engl J Med
|
80 |
Md Yuzaiful Md Yusof1, et al. |
2017 |
Effect of rituximab on the progression of rheumatoid arthritis‐related interstitial lung disease: 10 years' experience at a single centre. |
Rheumatology
|
76 |
K.R. Flaherty, et al. |
2019 |
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases. |
New Engl J Med
|
76 |
Tim Bongartz, et al. |
2010 |
Incidence and mortality of interstitial lung disease in rheumatoid arthritis: a population‐based study. |
Arthritis Rheum‐us
|
70 |
Ganesh Raghu, et al. |
2011 |
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence‐based guidelines for diagnosis and management. |
Am J Resp Crit Care
|
67 |
Aryeh Fischer, et al. |
2015 |
An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. |
Eur Respir J
|
67 |
Ganesh Raghu, et al. |
2018 |
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline |
Am J Respir Crit Care Med
|
63 |